Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

OTULINL inhibits detectable. 1 / 1

| 1

➶

eidos

"In striking contrast to OTULIN , which causes pronounced chemical shift perturbations and peak intensity changes to the HSQC spectra of both 15N-Ub and 15N-linear diUb reflective of binding interactions ( Figure 3B left panel , Figure 3C left panel respectively ) , FAM105A caused no detectable changes ( Figure 3B left panel , Figure 3C left panel respectively ) ."

31056421

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...